HealthTech For Care and EIT Health announce partnership to support the acceleration of European HealthTech companies

The first act of this collaboration will be the co-organisation and promotion of the HealthTech Innovation Days (HTID®), an event which fosters collaborations within European healthcare ecosystems in order to accelerate access to medical innovation for all patients.

HealthTech For Care, a new patient-centred endowment fund designed to promote and accelerate access to care for all patients, and EIT Health, the health community of the European Institute of Innovation and Technology - Health, have announced an institutional partnership. Through this partnership, HealthTech For Care and EIT Health will together co-promote a series of events aimed at meeting the economic and societal challenge of accelerating access to innovative healthcare solutions for all patients. The HealthTech Innovation Days (HTID®) will be the first event and will be held in Paris on October 5th and 6th, 2020.

EIT Health will act as an institutional partner to HTID® and, through such a partnership; participants will have the potential to interact with EIT Health’s extensive network of 150 partners throughout Europe. EIT Health’s access to deep knowledge of the European life science ecosystem will raise awareness and draw more European companies to participate in HTID®. EIT Health will also support and amplify HTID®’s visibility thanks to its pan-European network presence across different European countries.

Thanks to this partnership, HTID® will also provide a venue for future Venture Centre of Excellence (VCoE) in-person members’ meetings. The Venture Centre of Excellence is the first pan-European open innovation platform, currently being co-designed and launched by EIT Health and the European Investment Fund. The VCoE will offer its members access to an exclusive network within which to share deal flow opportunities with selected VC funds from EIF’s network. In turn, this will facilitate co- and direct-investment opportunities in Europe’s most promising Life Science start-ups, thereby supporting European innovation.

“We are thrilled to partner with HealthTech For Care to support the extensive developments taking place in European HealthTech, and to help accelerate this work to improve patient quality of life by promoting HTID® and everything the event stands for. The HTID® is an ideal event at which to bring together new VCoE members and the broader Life Science investment community for the first time. This is especially true as the VCoE’s operational teams will be based in Paris” said Jean-Marc Bourez, Managing Director of EIT Health France and Head of the VCoE.

“The partnership with EIT Health is a fantastic opportunity to build a more connected ecosystem. There are about 30,000 medical technology companies in Europe that are working to develop ground-breaking advances - our goal is to accelerate and support the development of these companies, and help patients get access to these advances,” said Maryvonne Hiance, President of HealthTech For Care.

Jan-Philipp Beck, Chief Executive Officer of EIT Health stated “At EIT Health we have created a fantastic ecosystem that connects over 150 top players from across Europe representing excellence in health innovation. We are set up to deliver new innovations and contribute to the re-imagining of European healthcare systems for their long-term sustainability. Partnering with HealthTech For Care to hold and co-organise the HTID event is an amazing opportunity to host the first bi-annual Venture Centre of Excellence members’ meeting. This connection with the EIF, the largest investor in European life science venture capital and the sector’s most active limited partner with ~ EUR 2bn in commitments, close to 100% market coverage and an annual volume of around EUR 300m, is a tremendous opportunity to mobilise the investment needed to scale.”

For more information, please visit: http://www.htid-paris.com.

About HealthTech For Care

The HealthTech For Care endowment fund, launched by France Biotech, is designed to support and promote access to care for all and, more specifically, to new medical technologies and drugs. The missions of the endowment fund are structured around three main areas: Supporting the development of the entire health ecosystem, accelerating the development of innovative therapies and treatments, and promoting better access to healthcare for patients in the French healthcare system and more widely throughout Europe. HealthTech For Care is administrated by Maryvonne Hiance, Elsy Boglioli, David Caumartin, Pierre Courteille, Eric Falcand, Marc Le Bozec, Cédric Moreau, Franck Mouthon, Christian Pierret and Christian Policard.

This article was first published on 28 May by EIT Health (French and English version).